Quarterly report · Q2
3937.TEDINET S100S6A8
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥5.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥541m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥502m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥495m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥495m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥574m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥337m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥337m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥6.4bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥5.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥5.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.7bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥504m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥498m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥221m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥111m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥33m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥169m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥447m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥235m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥25.57 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.6 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.68 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.58 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.24 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥25.1 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥47.57 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.88 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 67.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥300,000 |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥170m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥233m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥477m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥159m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥216m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥756m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥756m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥444m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥660m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥660m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 487
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember | 2131088000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember | 798236000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 2929325000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OtherReportableSegmentsMember | 600000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2929925000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 2929925000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember | 17491000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 17491000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OtherReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 17491000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -17491000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember | 2148579000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember | 798236000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 2946816000 | JPY |
| Net sales | CurrentYTDDuration_OtherReportableSegmentsMember | 600000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2947416000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -17491000 | JPY |
| Net sales | CurrentYTDDuration | 2929925000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember | 233279000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember | 477447000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 710726000 | JPY |
| Operating income | CurrentYTDDuration_OtherReportableSegmentsMember | 300000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 711026000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -169863000 | JPY |
| Operating income | CurrentYTDDuration | 541162000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-11-09 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第19期第2四半期(自 2023年7月1日 至 2023年9月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社Ubicomホールディングス | |
| Company name in english cover page | FilingDateInstant | Ubicom Holdings, Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 青木 正之 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区一番町21 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-5803-7339(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)上級執行役員コーポレート戦略本部長 北岡 明哲 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区一番町21 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-5803-7339(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)上級執行役員コーポレート戦略本部長 北岡 明哲 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E32408 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 39370 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社Ubicomホールディングス | |
| Filer name in english | FilingDateInstant | Ubicom Holdings, Inc. | |
| Fund name in japanese | FilingDateInstant | - | |
| Fund name in english | FilingDateInstant | - |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |